Boston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow BSX
Boston Scientific Corporation (BSX) Book value per share
Boston Scientific Corporation's book value per share at the end of fiscal 2025 was 16.5×, up 10.6% from 15.0× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 17.1×. Over the past ten years it has ranged from 4.7× (fiscal 2015) to 16.5× (fiscal 2025) — the current reading is the highest in ten years. Boston Scientific Corporation ranks 24th of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 16.5× | 10.55% |
| FY2024 | 15.0× | 11.25% |
| FY2023 | 13.4× | 9.42% |
| FY2022 | 12.3× | 5.12% |
| FY2021 | 11.7× | 8.03% |
| FY2020 | 10.8× | 8.48% |
| FY2019 | 10.0× | 57.83% |
| FY2018 | 6.3× | 23.46% |
| FY2017 | 5.1× | 3.19% |
| FY2016 | 5.0× | 5.25% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 17.1× | (2.61%) |
| Mar 2026 | 17.6× | 6.35% |
| Dec 2025 | 16.5× | 3.65% |
| Sep 2025 | 15.9× | 4.19% |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| STE STERIS plc compare | 74.0× |
| SYK Stryker Corporation compare | 62.6× |
| MDT Medtronic PLC compare | 39.7× |
| ABT Abbott Laboratories compare | 29.7× |
| GEHC GE HealthCare Technologies Inc. compare | 24.3× |
| EW Edwards Lifesciences Corporation compare | 18.6× |
| BSX Boston Scientific Corporation | 17.1× |
| PHG Koninklijke Philips N.V. compare | 14.0× |
| DXCM DexCom, Inc. compare | 6.9× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on BSX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement